Search
Home
>>
What's New
What's new
Adverse Drug Reaction case reporting in the first half of 2005
(2005-08-29)
SFDA invites comments on Good Supply Practice
(2005-08-29)
SFDA issues the Third Summary of Announcements Regarding Illegal Drug Advertisements in 2005
(2005-08-26)
The State Council promulgates Regulations for the Control of Narcotic Drugs and Psychotropic Drugs
(2005-08-25)
Seminar on International Pharmaceutical Cooperation Strategy held in Qingdao
(2005-08-23)
SFDA issues Procedures and Requirements for On-Site Inspection and Sampling for Drug Registration (interim)
(2005-08-11)
SFDA facilitates pharmaceutical IPR protection
(2005-07-29)
SFDA conducts inspection to the reviewing of advertisement of drugs, medical devices and health foods
(2005-07-29)
National Working Conference on Routine Supervision of Medical Device Manufacturing held in Xiamen
(2005-07-27)
SFDA and the General Administration of Customs jointly issue Announcement Regarding Drugs Imported as Exhibits
(2005-07-26)
SFDA starts a special inspection of the production of vaccines
(2005-07-21)
SFDA issues the No.65 announcement of drug administrative protection
(2005-07-12)
SFDA issues the No.64 announcement of drug administrative protection
(2005-07-12)
SFDA issues the No.63 announcement of drug administrative protection
(2005-07-12)
SFDA issues the No.62 announcement of drug administrative protection
(2005-07-12)
The State Council adopts A Plan for Infrastructure Construction within the Food and Drug Supervisory and Administrative System
(2005-07-07)
Wu Yi, on behalf of the State Council, reports the food safety and its supervision to the Standing Committee of the Tenth National People's Congress
(2005-07-07)
Wu Yi, on behalf of the State Council, reports the drug safety and its supervision to the Standing Committee of the Tenth National People's Congress
(2005-07-07)
SFDA holds its first hearing
(2005-07-07)
SFDA implements lot release process for human rabies vaccines
(2005-07-05)
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
Next >
(16/25)